Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
BPC-157 Product Specifications Purity: 99% (HPLC Verified) Appearance: White to off-white lyophilized powder Solubility: Refer to Certificate of Analysis for physicochemical properties Important Note: This product is strictly FOR RESEARCH USE ONLY and is intended exclusively for in vitro research and laboratory experimentation by qualified professionals
Cancer Ther
BPC157 is a COA-verified peptide, tested 99 % purity (HPLC verified) by BT Labs
Clinical Decision-Making Framework When considering BPC-157 therapy, evaluate: Severity and chronicity of the inflammatory condition Response to conventional first-line therapies Patient-specific factors including goals, expectations, and financial considerations Availability of evidence supporting use in the specific condition Potential for integration into comprehensive treatment approach BPC-157 is best positioned as adjunctive therapy or alternative option when conventional approaches have proven insufficient, rather than as first-line treatment for most inflammatory conditions
Whether clonal haematopoiesis is a surrogate of currently unknown shared risk factors, including inherited genetic risk (for example, mediated by rare variants), or has a more causal role in lung cancer remains unclear
US$ 20.18
US$ 23.89
US$ 22.98
US$ 29.36
US$ 21.20
US$ 21.24
US$ 28.66
US$ 21.16